Skip to main content
SpringerLink
Log in

Standard- vs reduced-dose DOAC for older adults: greater risk of bleeding with standard dose

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hayes KN, et al. Benefits and Harms of Standard Versus Reduced?Dose Direct Oral Anticoagulant Therapy for Older Adults With Multiple Morbidities and Atrial Fibrillation. Journal of the American Heart Association : 6 Nov 2023. Available from: URL: https://doi.org/10.1161/JAHA.122.029865

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Standard- vs reduced-dose DOAC for older adults: greater risk of bleeding with standard dose. Reactions Weekly 1984, 10 (2023). https://doi.org/10.1007/s40278-023-50241-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-50241-x

Search

Navigation